Sarepta Therapeutics is currently running multiple clinical trials in a few different countries. They are at various stages and for a range of ages. Sarepta issued an update for the Duchenne community to address questions about the status of their clinical trial programs and to make navigating them easier. This update includes more information on how the covid-19 vaccine affects potential participation in a gene therapy trial.
Read the community bulletin update in full below: